Efficacy of tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infected patients.

被引：0
|
作者：
Benhamou, Y
Piketty, C
Katlama, C
Rozembaum, W
Neau, D
Lafeuillade, A
Rey, D
Yazdanpanah, Y
Trimoulet, P
Fleury, H
机构：
[1] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
[2] Hop Georges Pompidou, Paris, France
[3] Hop Tenon, F-75970 Paris, France
[4] Hop Pellegrin, F-33076 Bordeaux, France
[5] Hop Chalucet, Toulon, France
[6] Hop Tourcoing, Strasbourg, France
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1155
引用
收藏
页码：712A / 713A
页数：2
相关论文
共 50 条
  • [21] Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus
    Dore, GJ
    Cooper, DA
    Pozniak, AL
    DeJesus, E
    Zhong, LJ
    Miller, MD
    Lu, B
    Cheng, AK
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07): : 1185 - 1192
  • [22] Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study
    Lok, James
    Veloz, Maria Fernanda Guerra
    Byrne, Ruth
    Carey, Ivana
    Childs, Kate
    Agarwal, Kosh
    Nelson, Mark
    CLINICAL THERAPEUTICS, 2024, 46 (02) : 159 - 163
  • [23] Two years safety and efficacy of tenofovir disoproxil fumarate (TDF) in patients with HBV-induced cirrhosis
    Strasser, S. I.
    Gane, E. J.
    Weilert, F.
    Sievert, W.
    George, J.
    Crawford, D.
    Ngu, M. C.
    Heathcote, E. J.
    Marcellin, P.
    Sorbel, J.
    Rousseau, F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A309 - A309
  • [24] Efficacy and safety of tenofovir disoproxil fumarate (TDF) in pregnancy to prevent perinatal transmission of hepatitis B virus (vol 61, pg 502, 2014)
    Greenup, Astrid-Jane
    Tan, Pok Kern
    Vi Nguyen
    Glass, Anne
    Davison, Scott
    Chatterjee, Ushmi
    Holdaway, Susan
    Samarasinghe, Dev
    Jackson, Kathy
    Locarnini, Stephen A.
    Levy, Miriam T.
    JOURNAL OF HEPATOLOGY, 2015, 63 (04) : 1054 - 1054
  • [25] Two Years Safety and Efficacy of Tenofovir Disoproxil Fumarate (TDF) in Patients with HBV-Induced Cirrhosis
    Buti, Maria
    Hadziyannis, Stephanos J.
    Mathurin, Philippe
    Urbanek, Petr
    Sherman, Morris
    Strasser, Simone I.
    Wang, Chia C.
    Petersen, Joerg
    Heathcote, Jenny
    Marcellin, Patrick
    Sorbel, Jeff
    Mondou, Elsa
    Anderson, Jane
    Rousseau, Franck
    GASTROENTEROLOGY, 2009, 136 (05) : A865 - A866
  • [26] From Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Perspectives in Pediatric Patients with Chronic Hepatitis B
    Rodrigo, Minna
    Hartley, Christopher
    Wasuwanich, Paul
    Van, Trung
    Karnsakul, Wikrom
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (12) : 1099 - 1106
  • [27] Differences of Efficacy Between Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate in Pregnant Women With Different Hepatitis B Virus DNA Loads
    Tao, Chengjing
    Zhou, Guanlun
    Jiang, Hongxiu
    Chen, Chao
    Ju, Yuhao
    Tao, Xingran
    Zhang, Ping
    Liu, Shuorong
    Han, Guorong
    INFECTIOUS MICROBES & DISEASES, 2024, 6 (03): : 134 - 140
  • [28] LONG-TERM FOLLOW-UP EVALUATION OF THE EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN A EUROPEAN MULTICENTER (NUCLEOS(T)IDE EXPERIENCED) HEPATITIS B VIRUS HBV-INFECTED COHORT
    van Boemmel, Florian
    De Man, Robert A.
    Ferenci, Peter
    Reijnders, Jurrien G.
    Bronowicki, Jean-Pierre
    Fueloep, Balazs
    Wedemeyer, Heiner
    Erhardt, Andreas
    Hueppe, Dietrich
    Bourliere, Marc
    Sarrazin, Christoph
    Trojan, Jorg
    Buggisch, Peter
    Petersen, Joerg
    Spengler, Ulrich
    Brost, Sylvia
    Pariente, Alexandre
    Schuchmann, Marcus
    Wasmuth, Hermann Elard
    Deterding, Katja
    Rutter, Karoline
    Feucht, Heinz-Hubert
    Wiedenmann, Bertram
    Berg, Thomas
    HEPATOLOGY, 2009, 50 (04) : 409A - 409A
  • [29] Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection
    Hofmann, Eveline
    Surial, Bernard
    Boillat-Blanco, Noemie
    Guenthard, Huldrych F.
    Stoeckle, Marcel
    Bernasconi, Enos
    Schmid, Patrick
    Calmy, Alexandra
    Suter-Riniker, Franziska
    Rauch, Andri
    Wandeler, Gilles
    Beguelin, Charles
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (04) : 730 - 733
  • [30] NO RESISTANCE TO TENOFOVIR DISOPROXIL FUMARATE (TDF) DETECTED FOLLOWING UP TO 192 WEEKS OF TREATMENT IN SUBJECTS MONO-INFECTED WITH CHRONIC HEPATITIS B VIRUS
    Snow-Lampart, Andrea
    Kitrinos, Kathryn M.
    Chappell, Brandi J.
    Myrick, Florence T.
    Schawalder, James C.
    Heathcote, E. Jenny
    Marcellin, Patrick
    Borroto-Esoda, Katyna
    HEPATOLOGY, 2010, 52 (04) : 977A - 977A
12345